Skip to main content
Top
Published in: Journal of Public Health 5/2019

Open Access 01-10-2019 | Original Article

Feasibility and organization of a population-based screening for pre-symptomatic type 1 diabetes in children — evaluation of the Fr1da study

Authors: Kerstin Kick, Verena S. Hoffmann, Karin Lange, Martin Lang, Otto Laub, Susanne Bechtold-Dalla Pozza, Dominik Böcker, Sonja Braig, Brigitte Dietz, Desiree Dunstheimer, Stefan Eber, Uwe Ermer, Antonia Gavazzeni, Eva-Maria Gerstl, Martin Götz, Friederike Huhn, Ursula Kuhnle-Krahl, Wolfgang Landendörfer, Georg Leipold, Karl-Heinz Leppik, Herbert Müller, Iris Müller, Nicole Nellen-Hellmuth, Christian Ockert, Christian Renner, Marina Sindichakis, Stefanie Tretter, Katharina Warncke, Christiane Winkler, Stefan Zeller, Peter Achenbach, Anette-Gabriele Ziegler

Published in: Journal of Public Health | Issue 5/2019

Login to get access

Abstract

Aim

Type 1 diabetes is the most common chronic metabolic disease in childhood. Often diagnosis comes with acutely life-threatening ketoacidosis and requires hospitalization. To avoid this, early detection of children at a pre-symptomatic stage is worthwhile. This task is met by a population-based screening in Bavaria, Germany – the Fr1da study. Here, we aim to evaluate the study concept, feasibility and medical evidence of the Fr1da study.

Methods

308 pediatricians, 16 diabetes care centers and participating families were asked to evaluate the Fr1da study by completing questionnaires assessing study concept and feasibility, educational program and study organization. The assessment was done anonymously. In order to evaluate the effectiveness of the training the parents had to answer questionnaires to assess their knowledge about diabetes.

Results

48% of pediatricians and 56% of pediatric diabetes care centers filled out the questionnaire. The majority positively judged the collaboration with the Fr1da coordinating center and the feasibility to integrate the project into daily routine. Medical evidence of the screening was recognized and most of the respondents endorsed the screening to be permanently integrated into standard care-program. The majority of parents would recommend the study to other parents with young children since they were satisfied with the collaboration with pediatricians, diabetes care centers and the coordinating center. Quality control of the educational program revealed good understanding of the teaching content.

Conclusion

The Fr1da study received high acceptance and recognition by both, health care providers and participating families, and demonstrated sustainable success with the developed educational program.
Appendix
Available only for authorised users
Literature
go back to reference Bonifacio E, Mathieu C, Nepom GT, Ziegler AG, Anhalt H, Haller MJ, Harrison LC, Hebrok M, Kushner JA, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson MA (2017) Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia 60(1):35–38. https://doi.org/10.1007/s00125-016-4144-8 CrossRefPubMed Bonifacio E, Mathieu C, Nepom GT, Ziegler AG, Anhalt H, Haller MJ, Harrison LC, Hebrok M, Kushner JA, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson MA (2017) Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia 60(1):35–38. https://​doi.​org/​10.​1007/​s00125-016-4144-8 CrossRefPubMed
go back to reference Elding Larsson H, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, Knip M, Veijola R, Lindblad B, Samuelsson U, Holl R, Haller MJ, on behalf of the TEDDY Study Group (2011) Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 34(11):2347–2352. https://doi.org/10.2337/dc11-1026 CrossRefPubMedPubMedCentral Elding Larsson H, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, Knip M, Veijola R, Lindblad B, Samuelsson U, Holl R, Haller MJ, on behalf of the TEDDY Study Group (2011) Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 34(11):2347–2352. https://​doi.​org/​10.​2337/​dc11-1026 CrossRefPubMedPubMedCentral
go back to reference Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark Å, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, Ziegler AG (2015a) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38(10):1964–1974. https://doi.org/10.2337/dc15-1419 CrossRefPubMedPubMedCentral Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark Å, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, Ziegler AG (2015a) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38(10):1964–1974. https://​doi.​org/​10.​2337/​dc15-1419 CrossRefPubMedPubMedCentral
go back to reference International Diabetes Federation (2013) IDF Diabetes Atlas. In: 6th edition International Diabetes Federation (2013) IDF Diabetes Atlas. In: 6th edition
go back to reference Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, Assfalg R, Weininger K, Wittich S, Löbner S, Beyerlein A, Nennstiel-Ratzel U, Lang M, Laub O, Dunstheimer D, Bonifacio E, Achenbach P, Winkler C, Ziegler AG, the Fr1da Study Group (2016) Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open 6(5):e011144. https://doi.org/10.1136/bmjopen-2016-011144 CrossRefPubMedPubMedCentral Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, Assfalg R, Weininger K, Wittich S, Löbner S, Beyerlein A, Nennstiel-Ratzel U, Lang M, Laub O, Dunstheimer D, Bonifacio E, Achenbach P, Winkler C, Ziegler AG, the Fr1da Study Group (2016) Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open 6(5):e011144. https://​doi.​org/​10.​1136/​bmjopen-2016-011144 CrossRefPubMedPubMedCentral
go back to reference Ziegler AG, Haupt F, Scholz M, Weininger K, Wittich S, Löbner S, Matzke C, Gezginci C, Riethausen S, Beyerlein A, Zillmer S, Amoroso M, Coles R, Powell M, Furmaniak J, Smith BR, Winkler C, Bonifacio E, Achenbach P (2016) 3 screen ELISA for high-throughput detection of Beta cell autoantibodies in capillary blood. Diabetes Technol Ther 18(11):687–693. https://doi.org/10.1089/dia.2016.0199 CrossRefPubMed Ziegler AG, Haupt F, Scholz M, Weininger K, Wittich S, Löbner S, Matzke C, Gezginci C, Riethausen S, Beyerlein A, Zillmer S, Amoroso M, Coles R, Powell M, Furmaniak J, Smith BR, Winkler C, Bonifacio E, Achenbach P (2016) 3 screen ELISA for high-throughput detection of Beta cell autoantibodies in capillary blood. Diabetes Technol Ther 18(11):687–693. https://​doi.​org/​10.​1089/​dia.​2016.​0199 CrossRefPubMed
Metadata
Title
Feasibility and organization of a population-based screening for pre-symptomatic type 1 diabetes in children — evaluation of the Fr1da study
Authors
Kerstin Kick
Verena S. Hoffmann
Karin Lange
Martin Lang
Otto Laub
Susanne Bechtold-Dalla Pozza
Dominik Böcker
Sonja Braig
Brigitte Dietz
Desiree Dunstheimer
Stefan Eber
Uwe Ermer
Antonia Gavazzeni
Eva-Maria Gerstl
Martin Götz
Friederike Huhn
Ursula Kuhnle-Krahl
Wolfgang Landendörfer
Georg Leipold
Karl-Heinz Leppik
Herbert Müller
Iris Müller
Nicole Nellen-Hellmuth
Christian Ockert
Christian Renner
Marina Sindichakis
Stefanie Tretter
Katharina Warncke
Christiane Winkler
Stefan Zeller
Peter Achenbach
Anette-Gabriele Ziegler
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Public Health / Issue 5/2019
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-018-0981-x

Other articles of this Issue 5/2019

Journal of Public Health 5/2019 Go to the issue